SUBSCRIBE: Print / eNewsletter
When presented with different options, patients perceived physicians that communicated face to face without the use of a computer as being more compassionate, professional, and as having better communication skills. Image © Lucky Business / Shutterstock.com
The Most Overlooked Symptom in Cancer Care
Mood disorders are common mental health sequelae of cancer, but depression in patients with cancer is frequently missed by healthcare providers, and there are many reasons for this oversight.
Duloxetine Relieves Joint Pain in AI-Treated Early Breast Cancer Patients
Duloxetine resulted in reduced AI-associated musculoskeletal symptoms compared with placebo in women with early-stage breast cancer.
It Is Easy to Forget
It is an exciting time for science, but lest we forget, those of us who provide direct patient care are also charged with practicing the art of medicine.
ASCO Value Framework Challenging to Apply in CLL
Although the ASCO Value Framework is an important step to quantify the value of cancer therapies, a new study has found that it has essential limitations for its application in clinical practice for the treatment of chronic lymphocytic leukemia.
Lymphoma Survivors After Transplant Still At Risk for Late Mortality
Two-year survivors with relapsed Hodgkin lymphoma or diffuse large B-cell lymphoma after transplant had an excess late mortality risk vs the general population.
MMR Deficiency Tests Underused in Young Adults With Colorectal Cancer
Utilization of testing for mismatch repair deficiency was poor and underused in a large population of patients with colorectal cancer.
Bevacizumab Does Not Improve Outcomes With Chemotherapy in Early NSCLC
The addition of bevacizumab to adjuvant chemotherapy failed to improve survival outcomes in patients with surgically resected early-stage NSCLC.
ctDNA Predicted Early Relapse in Resected Stage II/III Melanoma
Levels of circulating tumor DNA predicted worse outcomes including relapse and survival in patients with resected stage II/III melanoma, according to the results of a study.
Benefits, Barriers, and Challenges to Using Proton Therapy for Cancer Treatment
This video reviews the benefits of proton therapy and some of the barriers and challenges preventing the integration of the technology into regular practice.
FDA Approves Adjuvant Therapy for High-Risk Renal Cell Carcinoma
The FDA has approved a new indication for sunitinib (Sutent) to include the adjuvant treatment of renal cell carcinoma in patients at high risk of disease recurrence following nephrectomy.